Strategic Evidence and Market Access Expertise for Pharma and MedTech
Four Core Service Areas
01
HEOR Strategy
Clinical, economic & real-world evidence
02
Market Access and HTA
Reimbursement strategy & submission support
03
Evidence Strategy
Early-stage access planning for pharma & medtech
04
Scientific Communication
Value narratives & stakeholder materials
01 Health Economics & Outcomes Research (HEOR) Strategy
Developing evidence strategies that demonstrate clinical, economic, and real-world value to HTA bodies, payers, and healthcare decision-makers.
Support includes:
- HEOR evidence strategy and planning
- Evidence gap identification and prioritisation
- Outcomes strategy and endpoint relevance
- Evidence generation roadmaps
- Alignment of clinical, economic and access evidence needs
02 Market Access & HTA Strategy
Preparing your product for the realities of reimbursement and assessment.
Support includes:
- HTA evidence strategy
- Submission dossier development
- Submission support
- Payer-focused evidence positioning
- Evidence gap analysis
03 Evidence Strategy for MedTech & Pharma
Aligning development plans with future access requirements.
Support includes:
- Early value strategy during development
- Clinical and economic evidence alignment
- Real-world evidence planning
- Cross-functional evidence roadmaps
04 Scientific & Value Communication
Ensuring complex evidence translates into clear, compelling narratives.
Deliverables include:
- Value propositions
- Evidence summaries
- Stakeholder slide decks
- Internal strategy materials
Flexible Support
Engagements can be structured flexibly, from short advisory input to longer-term project support, depending on your needs.
Let’s Start the Conversation
If you’re developing a product, planning evidence generation, or preparing for market access, we would be pleased to arrange an informal discussion.